FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 21 filers reported holding FREELINE THERAPEUTICS HLDGS in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $1,093,000 | – | 70,000 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 1,361,064 | $24,853,000 | 7.00% |
Novo Holdings A/S | 2,361,229 | $43,116,000 | 1.85% |
Ally Bridge Group (NY) LLC | 425,000 | $7,761,000 | 1.33% |
TFG Asset Management GP Ltd | 750,000 | $13,695,000 | 0.92% |
SECTORAL ASSET MANAGEMENT INC | 657,494 | $12,006,000 | 0.85% |
FRAZIER MANAGEMENT LLC | 550,000 | $10,043,000 | 0.77% |
Eventide Asset Management | 2,485,656 | $44,266,000 | 0.68% |
Ovata Capital Management Ltd | 14,981 | $274,000 | 0.09% |
AXA S.A. | 551,476 | $10,070,000 | 0.03% |
Woodline Partners LP | 25,932 | $474,000 | 0.01% |